51 /100
HIGH RISK
Score updated May 30, 2026

XPON — Expion360 Inc. Dilution Risk Tracker

Track XPON dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track XPON — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
85
📊 Float Risk
17
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
61%
🔄 Reverse Split 70%
• 50-day avg $0.64 below $1 exchange minimum
• Only 5 months cash — financial pressure
🔁 Convertible Conversion 60%
• Major convertible overhang: 46% potential dilution
• Convertible risk score very high (85/100)
📉 Score Deterioration 40%
• Score rose 32 points recently (worsening)
🔔 Track XPON — Get forecast alerts →

💹 Market Data

Market Cap$6.08M
Shares Outstanding11.44M
Float10.49M
Cash$2.97M
Debt$907.0K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 87.7% shares (2025Q4 vs prior)
11 institutional holders · 262.8K shares
#1 VANGUARD GROUP INC 69.6K shares
#2 GEODE CAPITAL MANAGEMENT, LLC 68.6K shares
#3 Apollon Wealth Management, LLC 43.2K shares
+ 8 more holders Sign up free to view →

📉 Short Interest

Short Interest197.1K
Days to Cover1.6
% of Float1.9%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Sep 30, 2023
xbrl XBRL CONVERTIBLE Dec 31, 2021
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track XPON Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking XPON — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for XPON
📊 XPON FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 XPON Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.